In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

Cold, dry air is the ideal climate for viruses like the flu, phenomena and Respiratory Syncytial Virus (RSV), and these low ...

And the risk of this happening increases with age (especially after 50 years), a compromised immune system (e.g. in HIV and ...

This innovative single molecular diagnostic combination test swiftly identified and differentiated SARS-CoV-2, influenza A, ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

It comes after reports that flu and Covid 19 infections have increased across the Spanish ... rate of 794 cases per 100,000 ...

Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...

RESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose ...

As bird flu infections continue to rise among livestock and humans in the United States, surveillance is ramping up in Canada ...

A WINTER ‘quadruple-demic’ of nasty viruses is set to strike the UK in just weeks. RSV, a potentially lethal lung infection, ...

as the presentation is indistinguishable from other respiratory tract infections, and epidemics often overlap. The microbiologic confirmation of RSV infection is based on detecting the virus in a ...